Using bimodal MRI/fluorescence imaging to identify host angiogenic response to implants

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 16, 2015, Pages 5147-5152

  Berdichevski, Alexandra ^a   Yameen, Haneen Simaan ^a   Dafni, Hagit ^b   Neeman, Michal ^b   Seliktar, Dror ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Angiogenesis; Biomaterial scaffold; Contrast agents; Hydrogel; Tissue regeneration

Indexed keywords

BIOMATERIAL; FIBRINOGEN; FLUORESCENT DYE; MACROGOL; VASCULOTROPIN; CROSS LINKING REAGENT; HYDROGEL; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; CAPILLARY DENSITY; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; FLUORESCENCE IMAGING; HYDROGEL; IMMUNE RESPONSE; IMPLANT; IN VIVO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECTS; FLUORESCENCE; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; PHARMACOLOGY; PROSTHESES AND ORTHOSES;

RATTUS;

ANIMALS; CROSS-LINKING REAGENTS; FLUORESCENCE; HYDROGELS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PHYSIOLOGIC; PROSTHESES AND IMPLANTS; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84928252349     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1502232112     Document Type: Article

References (54)

1. Seliktar D (2012) Designing cell-compatible hydrogels for biomedical applications. Science 336(6085):1124-1128.
2. Malda J, Klein TJ, Upton Z (2007) The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng 13(9):2153-2162.
3. Kellner K, et al. (2002) Determination of oxygen gradients in engineered tissue using a fluorescent sensor. Biotechnol Bioeng 80(1):73-83.
4. Bland E, Dréau D, Burg KJ (2013) Overcoming hypoxia to improve tissue-engineering approaches to regenerative medicine. J Tissue Eng Regen Med 7(7):505-514.
5. Griffith CK, George SC (2009) The effect of hypoxia on in vitro prevascularization of a thick soft tissue. Tissue Eng Part A 15(9):2423-2434.
6. Yancopoulos GD, et al. (2000) Vascular-specific growth factors and blood vessel formation. Nature 407(6801):242-248.
7. Silva EA, Mooney DJ (2007) Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost 5(3):590-598.
8. Davies N, et al. (2008) The dosage dependence of VEGF stimulation on scaffold neovascularisation. Biomaterials 29(26):3531-3538.
9. Dor Y, et al. (2002) Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J 21(8):1939-1947.
10. Seliktar D, Zisch AH, Lutolf MP, Wrana JL, Hubbell JA (2004) MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing. J Biomed Mater Res A 68(4):704-716.
11. Formiga FR, et al. (2010) Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model. J Control Release 147(1):30-37.
12. Urech L, Bittermann AG, Hubbell JA, Hall H (2005) Mechanical properties, proteolytic degradability and biological modifications affect angiogenic process extension into native and modified fibrin matrices in vitro. Biomaterials 26(12):1369-1379.
13. Yilgor P, et al. (2013) An in vivo study on the effect of scaffold geometry and growth factor release on the healing of bone defects. J Tissue Eng Regen Med 7(9):687-696.
14. Dikovsky D, Bianco-Peled H, Seliktar D (2006) The effect of structural alterations of PEG-fibrinogen hydrogel scaffolds on 3-D cellular morphology and cellular migration. Biomaterials 27(8):1496-1506.
15. Artzi N, et al. (2011) In vivo and in vitro tracking of erosion in biodegradable materials using non-invasive fluorescence imaging. Nat Mater 10(9):704-709.
16. Aghion E, Levy G, Ovadia S (2012) In vivo behavior of biodegradable Mg-Nd-Y-Zr-Ca alloy. J Mater Sci Mater Med 23(3):805-812.
17. Yang Z, et al. (2012) In vitro and in vivo characterization of silk fibroin/gelatin composite scaffolds for liver tissue engineering. J Dig Dis 13(3):168-178.
18. Ge Y, Mei Z, Liu X (2011) Evaluation of daidzein-loaded chitosan microspheres in vivo after intramuscular injection in rats. Yakugaku Zasshi 131(12):1807-1812.
19. Cunha-Reis C, El Haj AJ, Yang X, Yang Y (2013) Fluorescent labeling of chitosan for use in non-invasive monitoring of degradation in tissue engineering. J Tissue Eng Regen Med 7(1):39-50.
20. Yang Y, Yiu HH, El Haj AJ (2005) On-line fluorescent monitoring of the degradation of polymeric scaffolds for tissue engineering. Analyst (Lond) 130(11):1502-1506.
21. Dello SA, et al. (2007) Liver volumetry plug and play: Do it yourself with ImageJ. World J Surg 31(11):2215-2221.
22. Zheng J, Allen C, Jaffray D, Chopra A (2004) PEGylated liposome co-encapsulating iohexol and gadoteridol for multimodal CT and MR imaging. Molecular Imaging and Contrast Agent Database (National Center for Biotechnology Information, Bethesda).
23. Dafni H, Israely T, Bhujwalla ZM, Benjamin LE, Neeman M (2002) Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: Magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin. Cancer Res 62(22):6731-6739.
24. Kotková Z, et al. (2010) Cyclodextrin-based bimodal fluorescence/MRI contrast agents: An efficient approach to cellular imaging. Chemistry 16(33):10094-10102.
25. Dafni H, Landsman L, Schechter B, Kohen F, Neeman M (2002) MRI and fluorescence microscopy of the acute vascular response to VEGF165: Vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor. NMR Biomed 15(2):120-131.
26. Ji W, et al. (2012) Biocompatibility and degradation characteristics of PLGA-based electrospun nanofibrous scaffolds with nanoapatite incorporation. Biomaterials 33(28):6604-6614.
27. Jiang HL, Tang GP, Weng LH, Zhu KJ (2001) In vivo degradation and biocompatibility of a new class of alternate poly(ester-anhydrides) based on aliphatic and aromatic diacids. J Biomater Sci Polym Ed 12(12):1281-1292.
28. Chwalek K, et al. (2011) Two-tier hydrogel degradation to boost endothelial cell morphogenesis. Biomaterials 32(36):9649-9657.
29. Ghanaati S (2012) Non-cross-linked porcine-based collagen I-III membranes do not require high vascularization rates for their integration within the implantation bed: A paradigm shift. Acta Biomater 8(8):3061-3072.
30. Sheridan MH, Shea LD, Peters MC, Mooney DJ (2000) Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release 64(1-3):91-102.
31. Phelps EA, Landázuri N, Thulé PM, Taylor WR, García AJ (2010) Bioartificial matrices for therapeutic vascularization. Proc Natl Acad Sci USA 107(8):3323-3328.
32. Ozawa CR, et al. (2004) Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113(4):516-527.
33. Richardson TP, Peters MC, Ennett AB, Mooney DJ (2001) Polymeric system for dual growth factor delivery. Nat Biotechnol 19(11):1029-1034.
34. Ehrbar M, et al. (2008) The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials 29(11):1720-1729.
35. Wong C, Inman E, Spaethe R, Helgerson S (2003) Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost 89(3):573-582.
36. Sahni A, Francis CW (2000) Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 96(12):3772-3778.
37. Ehrbar M, Metters A, Zammaretti P, Hubbell JA, Zisch AH (2005) Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release 101(1-3):93-109.
38. Rufaihah AJ, et al. (2013) Enhanced infarct stabilization and neovascularization mediated by VEGF-loaded PEGylated fibrinogen hydrogel in a rodent myocardial infarction model. Biomaterials 34(33):8195-8202.
39. Moon JJ, et al. (2010) Biomimetic hydrogels with pro-angiogenic properties. Biomaterials 31(14):3840-3847.
40. Martino MM, Briquez PS, Ranga A, Lutolf MP, Hubbell JA (2013) Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci USA 110(12):4563-4568.
41. Kim CH, Lee JH, Won JH, Cho MK (2011) Mesenchymal stem cells improve wound healing in vivo via early activation of matrix metalloproteinase-9 and vascular endothelial growth factor. J Korean Med Sci 26(6):726-733.
42. Maurer B, et al. (2014) Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis. Ann Rheum Dis 73(10): 1880-1887.
43. Yoshiji H, et al. (2003) Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 52(9):1347-1354.
44. Rappolee DA, Werb Z (1988) Secretory products of phagocytes. Curr Opin Immunol 1(1):47-55.
45. Luttikhuizen DT, Harmsen MC, Van Luyn MJ (2006) Cellular and molecular dynamics in the foreign body reaction. Tissue Eng 12(7):1955-1970.
46. Anderson JM, Rodriguez A, Chang DT (2008) Foreign body reaction to biomaterials. Semin Immunol 20(2):86-100.
47. Habib M, et al. (2011) A combined cell therapy and in-situ tissue-engineering approach for myocardial repair. Biomaterials 32(30):7514-7523.
48. Peled E, Boss J, Bejar J, Zinman C, Seliktar D (2007) A novel poly(ethylene glycol)-fibrinogen hydrogel for tibial segmental defect repair in a rat model. J Biomed Mater Res A 80(4):874-884.
49. Hoehn M, et al. (2002) Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 99(25):16267-16272.
50. Weir C, et al. (2008) Mesenchymal stem cells: Isolation, characterisation and in vivo fluorescent dye tracking. Heart Lung Circ 17(5):395-403.
51. Wang Y, et al. (2011) High MR sensitive fluorescent magnetite nanocluster for stem cell tracking in ischemic mouse brain. Nanomedicine (Lond Print) 7(6):1009-1019.
52. Gonen-Wadmany M, Goldshmid R, Seliktar D (2011) Biological and mechanical implications of PEGylating proteins into hydrogel biomaterials. Biomaterials 32(26): 6025-6033.
53. Lutolf MP, et al. (2003) Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics. Proc Natl Acad Sci USA 100(9):5413-5418.
54. Marler JJ, et al. (2000) Soft-tissue augmentation with injectable alginate and syngeneic fibroblasts. Plast Reconstr Surg 105(6):2049-2058.